查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1883045

抗生物膜剂市场规模、占有率、成长及全球产业分析：依类型、应用和地区划分的洞察与预测（2024-2032 年）

Anti-Biofilm Agents Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 261 Pages | 商品交期: 请询问到货日

价格

抗生物膜剂市场成长推动因素

随着全球慢性及急性伤口负担的日益加重，全球抗生物膜剂市场持续成长。 2024 年，该市场规模达到 13.8 亿美元，主要受生物膜发生率上升、伤口盛行率增加以及对先进伤口护理解决方案的需求增长的推动。预计到 2025 年，该市场规模将达到 15 亿美元，主要得益于医院、伤口诊所和家庭护理机构对生物膜产品的日益普及。在产品创新、公众意识提升和临床研究活动增加的推动下，预计到2032年，抗生物膜药物市场将显着增长至27.4亿美元。

北美将引领全球市场，在2024年占36.95%的市场。这主要归功于北美地区较高的医疗保健支出水准、完善的伤口管理基础设施以及先进伤口护理技术的日益普及。

市场推动因素

急性和慢性伤口的增加是推动抗生物膜药物需求的主要因素。生物膜存在于60%的慢性伤口和10%的急性伤口（MDPI，2024），会显着延缓伤口癒合并增加感染风险。糖尿病足溃疡、压疮和静脉性腿部溃疡是全球慢性伤口盛行率最高的几种类型。根据美国国家生物技术资讯中心 (NCBI，2023) 的数据，全球 6.3% 的糖尿病患者会发展为糖尿病足溃疡，其中许多溃疡与生物膜形成有关。

医院获得性压疮仍然普遍存在，英国的发生率为 8.7% (2021)。手术部位感染也在增加，全球发生率为 2.5% (美国国家医学图书馆，2023)。这些因素共同推动了对专用抗生物膜製剂（例如敷料、凝胶和粉末）的需求。

市场限制

儘管需求不断增长，但由于对生物膜风险缺乏认识以及慢性伤口诊断延迟，发展中国家的采用率仍然有限。发表在 "糖尿病足杂誌" (2023) 上的一项研究发现，诊断延迟时间为 15 至 126 天，这显着增加了生物膜的风险。保险覆盖范围有限、专业伤口护理人员短缺以及伤口护理指南不一致等因素进一步阻碍了印度、中国和巴西等新兴地区的市场扩张。

先进的抗生物膜敷料和新型抗菌技术的高昂成本也限制了低收入医疗机构的取得。

市场机会

慢性伤口盛行率的上升正促使各公司加大研发投入并开发新产品。康维特公司2024年的临床试验结果表明，其AQUACEL Ag+Extra敷料对静脉性腿部溃疡有效，再次印证了银基抗生物膜技术的作用。同样，该公司于2023年在美国推出的ConvaFoam敷料也确立了其在广谱伤口敷料领域的领先创新地位。

世界各地的政府和医疗机构也在开展提高公众意识的活动，旨在促进早期诊断并提高抗生物膜解决方案的采用率，尤其是在亚太和拉丁美洲地区，这些地区预计将实现长期增长。

市场挑战

在许多发展中地区，生物膜管理指南并未一致执行。临床医生培训不足、缺乏标准化的伤口评估系统以及抗生物膜疗法的不当使用，都会导致生物膜感染发展到晚期，治疗效果不佳。此外，高级敷料和专用产品的高昂成本限制了它们在资源匮乏地区的使用。

市场趋势

创新是塑造市场的核心趋势。研究越来越集中在奈米技术上，包括银奈米颗粒、氧化锌和蜂蜜基抗菌剂。根据美国国家生物技术资讯中心 (NCBI，2022) 的数据，80% 的慢性伤口中存在生物膜，因此对新一代抗生物膜系统有显着的临床需求。

领先的公司正与研究机构合作，推进生物膜管理。例如，Asep Medical Holdings 于 2022 年与 iFyber 合作，开发用于伤口护理的新型抗菌胜肽技术。

区域洞察

北美

预计到 2024 年，北美市场规模将达到 5.1 亿美元，这主要得益于先进伤口护理技术的广泛应用和强劲的医疗保健支出。美国仍然是最大的市场贡献者，这得益于其强大的研发投入和创新抗菌敷料的快速普及。

欧洲

由于慢性伤口的高发生率和较高的临床意识，欧洲占了相当大的市场占有率。像 Molnlycke AB 这样的公司正积极透过 EWMA 2025 等平台推广抗菌敷料。

亚太地区

预计亚太地区在 2025 年至 2032 年间将实现最高增长率，这主要得益于研究投入的增加、伤口护理基础设施的扩建以及人口老龄化导致慢性伤口发生率上升。

拉丁美洲、中东/非洲

成长的推动因素包括烧伤病例的增加、可支配收入的提高以及医院基础设施的扩建。巴西每年报告 100 万例烧伤病例，凸显了该地区的强劲需求。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场推动因素
  • 市场阻碍因素
  • 市场机遇
  • 市场趋势

第四章：主要发现

  • 主要疾病流行情况（主要国家/地区，2023/2024 年）
  • 主要产业趋势－併购与合作
  • 产品详情：抗生物膜剂、主要厂商

第五章：全球抗生物膜剂市场分析、洞察与预测 （2019-2032）

  • 市场分析、洞察与预测 - 依产品分类
    • 敷料
    • 软膏/凝胶
    • 粉剂
  • 市场分析、洞察与预测 - 依分子分类
    • 银
    • 碘
    • 蜂蜜
    • 其他
  • 市场分析、洞察与预测 - 依伤口类型分类
    • 慢性伤口
    • 急性伤口
  • 市场分析、洞察与预测 - 依最终用户分类
    • 医院
    • 伤口诊所
    • 家庭医疗保健机构
    • 其他
  • 市场分析、洞察与预测 - 依地区分类
    • 北部美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美抗生物膜剂市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 美国
    • 加拿大

第七章：欧洲抗生物膜剂市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 欧洲其他地区

第八章 亚太地区抗生物膜剂市场分析洞察与预测（2019-2032）

  • 依国家划分
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章：拉丁美洲抗生物膜剂市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章：中东与非洲抗生物膜剂市场分析、洞察与预测（2019-2032）

  • 依国家划分
    • 海湾合作委员会
    • 南亚非洲
    • 中东和非洲其他地区

第十一章 竞争分析

  • 全球市占率分析（2024 年）
  • 公司简介
  • 康维特公司 (Convatec Inc.)
  • 史密斯医疗 (Smith+Nephew)
  • 科乐普公司 (Coloplast A/S)
  • 索尔文图姆公司 (Solventum)
  • 莫尔尼克公司 (Molnlycke AB)
  • URGO MEDICAL
  • Imbed Biosciences
Product Code: FBI113668

Growth Factors of anti-biofilm agents Market

The global anti-biofilm agents market continues to gain traction as the burden of chronic and acute wounds rises worldwide. In 2024, the market was valued at USD 1.38 billion, supported by increasing biofilm formation cases, higher wound prevalence, and a growing shift toward advanced wound care solutions. The market is expected to reach USD 1.50 billion in 2025, driven by increasing adoption of anti-biofilm products across hospitals, wound clinics, and home care settings. By 2032, the anti-biofilm agents market is projected to grow significantly to USD 2.74 billion, fueled by product innovation, growing awareness, and increased clinical research activity.

North America dominated the global market in 2024, capturing 36.95% of total share, largely due to high healthcare spending, strong wound management infrastructure, and rising adoption of advanced wound care technologies.

Market Drivers

The rise in acute and chronic wounds is the primary driver of anti-biofilm agent demand. Biofilms, which occur in 60% of chronic wounds and 10% of acute wounds (MDPI, 2024), significantly delay healing and increase the risk of infection. Diabetic foot ulcers, pressure ulcers, and venous leg ulcers represent the largest contributor to chronic wound prevalence worldwide. According to NCBI (2023), 6.3% of diabetic patients globally develop diabetic foot ulcers, many of which involve biofilm formation.

Hospital-acquired pressure ulcers remain widespread, with incidence rates reaching 8.7% in the U.K. (2021). Surgical site infections are also on the rise, with a global pooled incidence of 2.5% (National Library of Medicine, 2023). These factors collectively increase the need for specialized anti-biofilm agents, including dressings, gels, and powders.

Market Restraints

Despite rising demand, adoption in developing nations remains limited due to low awareness of biofilm risks and delayed diagnosis of chronic wounds. A study published in The Diabetic Foot Journal (2023) found diagnostic delays ranging from 15 to 126 days, significantly increasing biofilm risk. Limited reimbursement, lack of specialist wound-care professionals, and inconsistent wound-care guidelines further hinder market expansion in emerging regions such as India, China, and Brazil.

The high cost of advanced anti-biofilm dressings and novel antimicrobial technologies also limits access in low-income healthcare settings.

Market Opportunities

The rising prevalence of chronic wounds is encouraging companies to increase R&D investments and pursue new product development. Convatec's 2024 clinical results demonstrated the effectiveness of its AQUACEL Ag+ Extra dressing in venous leg ulcers, reaffirming the role of silver-based anti-biofilm technologies. Similarly, the company's 2023 U.S. launch of ConvaFoam positioned it as a key innovator in broad-spectrum wound dressings.

Governments and healthcare organizations globally are also launching awareness initiatives to promote early diagnosis and improve adoption of anti-biofilm solutions, particularly in Asia Pacific and Latin America-regions expected to show strong long-term growth.

Market Challenges

Biofilm management guidelines are not implemented consistently across many developing regions. Limited clinician training, lack of standardized wound assessment systems, and inconsistent use of anti-biofilm therapies contribute to late-stage biofilm infections and poor outcomes. Additionally, the high cost of advanced dressings and specialized products restricts usage in resource-constrained settings.

Market Trends

Innovation is a core trend shaping the market. Studies are increasingly focused on nanotechnology, including silver nanoparticles, zinc oxide, and honey-based antimicrobials. According to NCBI (2022), 80% of chronic wounds contain biofilms, creating a significant clinical need for next-generation anti-biofilm systems.

Key players are partnering with research organizations to advance biofilm management. For example, Asep Medical Holdings partnered with iFyber in 2022 to develop novel antimicrobial peptide technologies for wound care applications.

Regional Insights

North America

North America accounted for USD 0.51 billion in 2024, driven by high adoption of advanced wound care and robust healthcare expenditure. The U.S. remains the largest contributor due to strong R&D funding and rapid uptake of innovative antimicrobial dressings.

Europe

Europe holds a significant market share due to high chronic wound prevalence and strong clinical awareness. Companies such as Molnlycke AB actively promote antimicrobial dressings through platforms like EWMA 2025.

Asia Pacific

Asia Pacific is expected to record the highest growth between 2025 and 2032, supported by rising research activity, expanding wound care infrastructure, and growing cases of chronic wounds across aging populations.

Latin America & Middle East/Africa

Growth is driven by increasing burn injuries, rising disposable income, and expanding hospital infrastructure. Brazil reports 1 million burn cases annually, highlighting strong regional demand.

Conclusion

With market value rising from USD 1.38 billion in 2024 to USD 2.74 billion by 2032, the anti-biofilm agents market is set for strong expansion. Growing wound prevalence, rising R&D investments, and rapid innovation in antimicrobial technologies will continue driving global adoption throughout the forecast period.

Segmentation

By Product

  • Dressings
  • Ointments / Gels
  • Powders

By Molecule

  • Silver
  • Iodine
  • Honey
  • Others

By Wound Type

  • Chronic Wounds
  • Acute Wounds

By End User

  • Hospitals
  • Wound Clinics
  • Home Care Settings
  • Others

By Region

  • North America (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • U.S.
    • Canada
  • Europe (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • China
    • Japan
    • India
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product, By Molecule, By Wound Type, By End User, and By Country)
    • GCC
    • South Africa
    • Rest of Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Diseases, Key Countries, 2023/2024
  • 4.2. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.3. Detailed Product Offerings: Anti-biofilm Agents, Key Players

5. Global Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2019-2032

  • 5.1. Market Analysis, Insights and Forecast - By Product
    • 5.1.1. Dressings
    • 5.1.2. Ointments / Gels
    • 5.1.3. Powders
  • 5.2. Market Analysis, Insights and Forecast - By Molecule
    • 5.2.1. Silver
    • 5.2.2. Iodine
    • 5.2.3. Honey
    • 5.2.4. Others
  • 5.3. Market Analysis, Insights and Forecast - By Wound Type
    • 5.3.1. Chronic Wounds
    • 5.3.2. Acute Wounds
  • 5.4. Market Analysis, Insights and Forecast - By End-user
    • 5.4.1. Hospitals
    • 5.4.2. Wound Clinics
    • 5.4.3. Homecare Settings
    • 5.4.4. Others
  • 5.5. Market Analysis, Insights and Forecast - By Region
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East & Africa

6. North America Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2019-2032

  • 6.1. Market Analysis, Insights and Forecast - By Product
    • 6.1.1. Dressings
    • 6.1.2. Ointments / Gels
    • 6.1.3. Powders
  • 6.2. Market Analysis, Insights and Forecast - By Molecule
    • 6.2.1. Silver
    • 6.2.2. Iodine
    • 6.2.3. Honey
    • 6.2.4. Others
  • 6.3. Market Analysis, Insights and Forecast - By Wound Type
    • 6.3.1. Chronic Wounds
    • 6.3.2. Acute Wounds
  • 6.4. Market Analysis, Insights and Forecast - By End-user
    • 6.4.1. Hospitals
    • 6.4.2. Wound Clinics
    • 6.4.3. Homecare Settings
    • 6.4.4. Others
  • 6.5. Market Analysis, Insights and Forecast - By Country
    • 6.5.1. U.S.
    • 6.5.2. Canada

7. Europe Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2019-2032

  • 7.1. Market Analysis, Insights and Forecast - By Product
    • 7.1.1. Dressings
    • 7.1.2. Ointments / Gels
    • 7.1.3. Powders
  • 7.2. Market Analysis, Insights and Forecast - By Molecule
    • 7.2.1. Silver
    • 7.2.2. Iodine
    • 7.2.3. Honey
    • 7.2.4. Others
  • 7.3. Market Analysis, Insights and Forecast - By Wound Type
    • 7.3.1. Chronic Wounds
    • 7.3.2. Acute Wounds
  • 7.4. Market Analysis, Insights and Forecast - By End-user
    • 7.4.1. Hospitals
    • 7.4.2. Wound Clinics
    • 7.4.3. Homecare Settings
    • 7.4.4. Others
  • 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 7.5.1. U.K.
    • 7.5.2. Germany
    • 7.5.3. France
    • 7.5.4. Italy
    • 7.5.5. Spain
    • 7.5.6. Russia
    • 7.5.7. Rest of Europe

8. Asia Pacific Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2019-2032

  • 8.1. Market Analysis, Insights and Forecast - By Product
    • 8.1.1. Dressings
    • 8.1.2. Ointments / Gels
    • 8.1.3. Powders
  • 8.2. Market Analysis, Insights and Forecast - By Molecule
    • 8.2.1. Silver
    • 8.2.2. Iodine
    • 8.2.3. Honey
    • 8.2.4. Others
  • 8.3. Market Analysis, Insights and Forecast - By Wound Type
    • 8.3.1. Chronic Wounds
    • 8.3.2. Acute Wounds
  • 8.4. Market Analysis, Insights and Forecast - By End-user
    • 8.4.1. Hospitals
    • 8.4.2. Wound Clinics
    • 8.4.3. Homecare Settings
    • 8.4.4. Others
  • 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 8.5.1. China
    • 8.5.2. India
    • 8.5.3. Japan
    • 8.5.4. Australia
    • 8.5.5. Southeast Asia
    • 8.5.6. Rest of Asia Pacific

9. Latin America Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2019-2032

  • 9.1. Market Analysis, Insights and Forecast - By Product
    • 9.1.1. Dressings
    • 9.1.2. Ointments / Gels
    • 9.1.3. Powders
  • 9.2. Market Analysis, Insights and Forecast - By Molecule
    • 9.2.1. Silver
    • 9.2.2. Iodine
    • 9.2.3. Honey
    • 9.2.4. Others
  • 9.3. Market Analysis, Insights and Forecast - By Wound Type
    • 9.3.1. Chronic Wounds
    • 9.3.2. Acute Wounds
  • 9.4. Market Analysis, Insights and Forecast - By End-user
    • 9.4.1. Hospitals
    • 9.4.2. Wound Clinics
    • 9.4.3. Homecare Settings
    • 9.4.4. Others
  • 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 9.5.1. Brazil
    • 9.5.2. Mexico
    • 9.5.3. Rest of Latin America

10. Middle Est & Africa Anti-Biofilm Agents Market Analysis, Insights and Forecast, 2019-2032

  • 10.1. Market Analysis, Insights and Forecast - By Product
    • 10.1.1. Dressings
    • 10.1.2. Ointments / Gels
    • 10.1.3. Powders
  • 10.2. Market Analysis, Insights and Forecast - By Molecule
    • 10.2.1. Silver
    • 10.2.2. Iodine
    • 10.2.3. Honey
    • 10.2.4. Others
  • 10.3. Market Analysis, Insights and Forecast - By Wound Type
    • 10.3.1. Chronic Wounds
    • 10.3.2. Acute Wounds
  • 10.4. Market Analysis, Insights and Forecast - By End-user
    • 10.4.1. Hospitals
    • 10.4.2. Wound Clinics
    • 10.4.3. Homecare Settings
    • 10.4.4. Others
  • 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
    • 10.5.1. GCC
    • 10.5.2. South Africa
    • 10.5.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2024)
  • 11.2. Company Profiles
    • 11.2.1. Convatec Inc.
      • 11.2.1.1. Overview
      • 11.2.1.2. Products
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Smith+Nephew
      • 11.2.2.1. Overview
      • 11.2.2.2. Products
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Coloplast A/S
      • 11.2.3.1. Overview
      • 11.2.3.2. Products
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. Solventum
      • 11.2.4.1. Overview
      • 11.2.4.2. Products
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. Molnlycke AB
      • 11.2.5.1. Overview
      • 11.2.5.2. Products
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. URGO MEDICAL
      • 11.2.6.1. Overview
      • 11.2.6.2. Products
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. Imbed Biosciences
      • 11.2.7.1. Overview
      • 11.2.7.2. Products
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 2: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2019-2032
  • Table 3: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2019-2032
  • Table 4: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 5: Global Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Region, 2019-2032
  • Table 6: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 7: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2019-2032
  • Table 8: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2019-2032
  • Table 9: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 10: North America Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country, 2019-2032
  • Table 11: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 12: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2019-2032
  • Table 13: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2019-2032
  • Table 14: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 15: Europe Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 16: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 17: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2019-2032
  • Table 18: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2019-2032
  • Table 19: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 20: Asia Pacific Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 21: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 22: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2019-2032
  • Table 23: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2019-2032
  • Table 24: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 25: Latin America Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032
  • Table 26: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Product, 2019-2032
  • Table 27: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Molecule, 2019-2032
  • Table 28: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by Wound Type, 2019-2032
  • Table 29: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, by End User, 2019-2032
  • Table 30: Middle East & Africa Anti-biofilm Agents Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2019-2032

List of Figures

  • Figure 1: Global Anti-biofilm Agents Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
  • Figure 2: Global Anti-biofilm Agents Market Value Share (%), by Product, 2024 & 2032
  • Figure 3: Global Anti-biofilm Agents Segmental Opportunity Index, By Product, 2024
  • Figure 4: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By Product, 2024 & 2032
  • Figure 5: Global Anti-biofilm Agents Market Value Share (%), by Molecule, 2024 & 2032
  • Figure 6: Global Anti-biofilm Agents Segmental Opportunity Index, By Molecule, 2024
  • Figure 7: Global Anti-biofilm Agents Segmental Opportunity Index, By Molecule, 2024
  • Figure 8: Global Anti-biofilm Agents Market Value Share (%), by Wound Type, 2024 & 2032
  • Figure 9: Global Anti-biofilm Agents Segmental Opportunity Index, By Wound Type, 2024
  • Figure 10: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By Wound Type, 2024 & 2032
  • Figure 11: Global Anti-biofilm Agents Market Value Share (%), by End User, 2024 & 2032
  • Figure 12: Global Anti-biofilm Agents Segmental Opportunity Index, By End User, 2024
  • Figure 13: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By End User, 2024 & 2032
  • Figure 14: Global Anti-biofilm Agents Market Value Share (%), by Region, 2024 & 2032
  • Figure 15: Global Anti-biofilm Agents Segmental Opportunity Index, By Region, 2024
  • Figure 16: Global Anti-biofilm Agents Segmental Opportunity (USD billion), By Region, 2024 & 2032
  • Figure 17: North America Anti-biofilm Agents Market Value (USD billion), by Product, 2024 & 2032
  • Figure 18: North America Anti-biofilm Agents Market Value Share (%), by Product, 2024
  • Figure 19: North America Anti-biofilm Agents Market Value (USD billion), by Molecule, 2024 & 2032
  • Figure 20: North America Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2024 & 2032
  • Figure 21: North America Anti-biofilm Agents Market Value (USD billion), by End User, 2024 & 2032
  • Figure 22: North America Anti-biofilm Agents Market Value (USD billion), By Country, 2024 & 2032
  • Figure 23: Europe Anti-biofilm Agents Market Value (USD billion), by Product, 2024 & 2032
  • Figure 24: Europe Anti-biofilm Agents Market Value Share (%), by Product, 2024
  • Figure 25: Europe Anti-biofilm Agents Market Value (USD billion), by Molecule, 2024 & 2032
  • Figure 26: Europe Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2024 & 2032
  • Figure 27: Europe Anti-biofilm Agents Market Value (USD billion), by End User, 2024 & 2032
  • Figure 28: Europe Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 29: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by Product, 2024 & 2032
  • Figure 30: Asia Pacific Anti-biofilm Agents Market Value Share (%), by Product, 2024
  • Figure 31: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by Molecule, 2024 & 2032
  • Figure 32: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2024 & 2032
  • Figure 33: Asia Pacific Anti-biofilm Agents Market Value (USD billion), by End User, 2024 & 2032
  • Figure 34: Asia Pacific Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 35: Latin America Anti-biofilm Agents Market Value (USD billion), by Product, 2024 & 2032
  • Figure 36: Latin America Anti-biofilm Agents Market Value Share (%), by Product, 2024
  • Figure 37: Latin America Anti-biofilm Agents Market Value (USD billion), by Molecule, 2024 & 2032
  • Figure 38: Latin America Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2024 & 2032
  • Figure 39: Latin America Anti-biofilm Agents Market Value (USD billion), by End User, 2024 & 2032
  • Figure 40: Latin America Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 41: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by Product, 2024 & 2032
  • Figure 42: Middle East & Africa Anti-biofilm Agents Market Value Share (%), by Product, 2024
  • Figure 43: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by Molecule, 2024 & 2032
  • Figure 44: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by Wound Type, 2024 & 2032
  • Figure 45: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), by End User, 2024 & 2032
  • Figure 46: Middle East & Africa Anti-biofilm Agents Market Value (USD billion), By Country/ Sub-region, 2024 & 2032
  • Figure 47: Global Anti-biofilm Agents Market Share (%), By Company, 2024